| Financial Year |
March 31 2023 |
| Monetary Funds |
532,897,509.34 |
| Held-for-trading Financial Assets |
64,951,017.79 |
| Notes Receivable |
1,469,934.00 |
| Accounts Receivable |
52,021,115.05 |
| Advances to Suppliers |
5,956,815.62 |
| Other Receivables |
1,154,828.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
79,077,286.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
14,843,121.77 |
| Other Current Assets |
1,169,178.35 |
| Total Current Assets |
759,299,655.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,970,037.64 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
92,297,172.14 |
| Under-construction Projects |
26,519,049.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,105,785.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
956,719.98 |
| Deferred Income Tax Assets |
4,524,859.62 |
| Other Non-Current Assets |
50,742.57 |
| Sub-Total of Non-Current Assets |
167,213,635.15 |
| Total Assets |
926,513,290.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,686,387.24 |
| Accounts Payable |
73,675,591.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,307,385.94 |
| Taxes Payable |
1,151,804.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,372,563.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
342,977.33 |
| Other Current Liabilities |
7,054,123.96 |
| Sub-Total of Current Liabilities |
117,810,603.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
366,566.14 |
| Deferred Income Tax Liabilities |
232,683.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,778,716.08 |
| Total Liabilities |
127,589,319.66 |
| Paid-In Capital(Or Share Stock) |
177,866,667.00 |
| Capital Surplus |
373,731,282.68 |
| Surplus Reserve |
38,669,670.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
200,302,834.66 |
| Minority Stockholder's Interest |
8,353,515.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
790,570,455.18 |
| Owner's Equity（Stockholder's Equity） |
798,923,971.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
926,513,290.75 |
